Skip to main content
. 2022 Sep 28;610(7930):161–172. doi: 10.1038/s41586-022-05192-0

Extended Data Fig. 2. MuFAP-IL2v is biologically active in vivo but non-specifically expands CD8 T cells.

Extended Data Fig. 2

a, Chronically LCMV-infected mice (> day 40 post-infection) were left untreated or treated with muPD-L1, muPD-L1 + muFAP-IL2wt, and muPD-L1 + muFAP-IL2v for 2 weeks and then analyzed for expansion of CD8 T cells. b, Representative FACS plots for CD8+ T cells in PBMCs. c, Numbers of CD8+ T cells per 106 PBMCs. d, Representative FACS plots for CD44 and PD-1 expressions on CD8+ T cells in PBMCs. e, Numbers of CD44+PD-1 and CD44+PD-1+ CD8+ T cells per 106 PBMCs. Results were pooled from 3-4 experiments with n = 2–5 mice per group in each experiment. Data are presented as geometric mean and 95% CI with p values. Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple comparison test. Untx, untreated.

Source Data